Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Total 13F shares
-
157,059,318
-
Share change
-
+1,080,887
-
Total reported value
-
$11,053,134,526
-
Put/Call ratio
-
105%
-
Price per share
-
$70.39
-
Number of holders
-
545
-
Value change
-
+$61,380,607
-
Number of buys
-
259
-
Number of sells
-
227
Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2024
As of 31 Mar 2024,
BIO-TECHNE Corp - COMMON STOCK (TECH) was held by
545 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
157,059,318 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, BAMCO INC /NY/, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, NEUBERGER BERMAN GROUP LLC, DF DENT & CO INC, and AMERIPRISE FINANCIAL INC.
This page lists
546
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.